As of 2026-03-05, the Relative Valuation of Vanda Pharmaceuticals Inc (VNDA) is (36.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.20 USD, the upside of Vanda Pharmaceuticals Inc based on Relative Valuation is -540.9%.
The range of the Relative Valuation is (33.42) - (38.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.0x - 27.3x | 24.0x |
| Forward P/E multiples | 23.5x - 29.7x | 26.7x |
| Fair Price | (33.42) - (38.95) | (36.15) |
| Upside | -507.6% - -575.0% | -540.9% |
| Date | P/E |
| 2026-03-04 | -5.76 |
| 2026-03-03 | -5.50 |
| 2026-03-02 | -5.73 |
| 2026-02-27 | -6.25 |
| 2026-02-26 | -6.04 |
| 2026-02-25 | -5.81 |
| 2026-02-24 | -5.73 |
| 2026-02-23 | -5.72 |
| 2026-02-20 | -4.04 |
| 2026-02-19 | -4.28 |
| 2026-02-18 | -4.23 |
| 2026-02-17 | -4.35 |
| 2026-02-13 | -4.27 |
| 2026-02-12 | -4.30 |
| 2026-02-11 | -5.22 |
| 2026-02-10 | -5.21 |
| 2026-02-09 | -5.27 |
| 2026-02-06 | -5.31 |
| 2026-02-05 | -5.07 |
| 2026-02-04 | -5.33 |
| 2026-02-03 | -5.65 |
| 2026-02-02 | -5.43 |
| 2026-01-30 | -5.29 |
| 2026-01-29 | -5.46 |
| 2026-01-28 | -5.40 |
| 2026-01-27 | -5.63 |
| 2026-01-26 | -5.46 |
| 2026-01-23 | -5.62 |
| 2026-01-22 | -5.69 |
| 2026-01-21 | -5.57 |
| 2026-01-20 | -5.41 |
| 2026-01-16 | -5.24 |
| 2026-01-15 | -5.23 |
| 2026-01-14 | -5.40 |
| 2026-01-13 | -5.22 |
| 2026-01-12 | -5.20 |
| 2026-01-09 | -5.14 |
| 2026-01-08 | -5.15 |
| 2026-01-07 | -5.99 |
| 2026-01-06 | -5.71 |
| 2026-01-05 | -5.52 |
| 2026-01-02 | -5.79 |
| 2025-12-31 | -6.19 |
| 2025-12-30 | -4.93 |
| 2025-12-29 | -5.05 |
| 2025-12-26 | -4.94 |
| 2025-12-24 | -4.85 |
| 2025-12-23 | -4.80 |
| 2025-12-22 | -4.93 |
| 2025-12-19 | -4.74 |